Hence then, the article about pleopharma inc reports positive phase 2b clinical trial data for mitigation of cannabis withdrawal a potential first in class treatment was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PLEOPHARMA, INC. REPORTS POSITIVE PHASE 2b CLINICAL TRIAL DATA FOR MITIGATION OF CANNABIS WITHDRAWAL: A POTENTIAL FIRST IN CLASS TREATMENT )
Last updated :
Also on site :
- Toxic Homes, Terrible Dilemma: Oscar Contender ‘Still Standing’ Documents Homeowner Nightmare After LA Wildfires – SFFILM Doc Stories
- Rock Hall of Fame 2026: Phil Collins, Oasis, Iron Maiden and Wu-Tang Clan Are Being Inducted This Saturday — Here’s When You Can Watch
- In 1885, Dr Pepper Was Born in a Texas Drugstore—141 Years Later, Hobby Lobby Is Selling a $12 T-Shirt That Celebrates Its History
